Access to anti-retroviral drugs, female in Tunisia
Tunisia: Access to anti-retroviral drugs, female was 33.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Tunisia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Tunisia stood at 33.0%.
That represents a change of up 65.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Tunisia peaked at 37.0% in 2022 and was at its lowest, 0.0%, in 2000.
Tunisia ranks 133rd of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Tunisia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 2.0% | — |
| 2002 | 3.0% | +50.0% |
| 2003 | 3.0% | +0.0% |
| 2004 | 4.0% | +33.3% |
| 2005 | 4.0% | +0.0% |
| 2006 | 5.0% | +25.0% |
| 2007 | 6.0% | +20.0% |
| 2008 | 7.0% | +16.7% |
| 2009 | 10.0% | +42.9% |
| 2010 | 10.0% | +0.0% |
| 2011 | 11.0% | +10.0% |
| 2012 | 14.0% | +27.3% |
| 2013 | 16.0% | +14.3% |
| 2014 | 20.0% | +25.0% |
| 2015 | 21.0% | +5.0% |
| 2016 | 23.0% | +9.5% |
| 2017 | 25.0% | +8.7% |
| 2018 | 28.0% | +12.0% |
| 2019 | 31.0% | +10.7% |
| 2020 | 33.0% | +6.5% |
| 2021 | 33.0% | +0.0% |
| 2022 | 37.0% | +12.1% |
| 2023 | 33.0% | -10.8% |
| 2024 | 33.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.4% | 0.0% | 10.0% | 10 |
| 2010s | 19.9% | 10.0% | 31.0% | 10 |
| 2020s | 33.8% | 33.0% | 37.0% | 5 |
Countries ranked near Tunisia
More gender data for Tunisia
- Child population (UN estimates and projections) 2,590 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.76 % change on previous year (2030)
- Population 10,039 (2030)
- Working-age population (UN estimates and projections) 10,039 (2030)
- Population (UN estimates and projections), annual growth rate 1.2 % change on previous year (2030)
- Age population, age 00, female, interpolated 78,462 (2025)
- Age population, age 00, male, interpolated 82,178 (2025)
- Age population, age 01, female, interpolated 79,945 (2025)
- Age population, age 01, male, interpolated 83,799 (2025)
- Age population, age 02, female, interpolated 81,489 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Tunisia?
- Access to anti-retroviral drugs, female in Tunisia was 33.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Tunisia?
- The highest recorded value was 37.0% in 2022.
- What is the lowest access to anti-retroviral drugs, female recorded in Tunisia?
- The lowest recorded value was 0.0% in 2000.
- How does Tunisia rank for access to anti-retroviral drugs, female?
- Tunisia ranks 133rd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Tunisia?
- Over the last ten years it is up 65.0%. The long-run trend across the full record is volatile.
- Where does this Tunisia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.